Advancing Liver Gene Therapy: Enhanced Transduction with GalNAc-Bioconjugated rAAV Capsids
Preprint
Abstract
This study investigates novel approaches to improve targeted gene delivery to the liver, a crucial organ for metabolic processes that faces vulnerabilities from various pathologies. Adeno-associated virus (AAV)-based gene therapy has emerged as a promising approach for liver targeting, with numerous investigational avenues. However, administration of high doses of AAV vectors present safety concerns, often requiring the use of corticosteroids and immunosuppression to mitigate immune adverse events. To address this, substantial efforts are underway to engineer optimized capsids to enhance the efficiency and specificity of recombinant AAV (rAAV) targeting hepatocytes, aiming to reduce required dosages. In this study, we employed bioconjugation chemistry to target the Asialoglycoprotein receptor (ASGPR), a C-type lectin abundantly expressed at the surface of hepatocyte membranes. We demonstrated that covalently attaching carbohydrates derived from GalNAc (a known ASGPR ligand) to lysine amino-acids on the rAAV2 capsid significantly enhanced in vivo liver transduction efficiency in mice. These optimized vectors present a promising avenue for the treatment of a spectrum of liver diseases, providing an alternative solution within the framework of liver gene therapy.Keywords
All Related Versions
- Published version: Biomedicine & Pharmacotherapy, 189.
This publication has 33 references indexed in Scilit:
- Mannose-coupled AAV2: A second-generation AAV vector for increased retinal gene therapy efficiencyMolecular Therapy - Methods & Clinical Development, 2024
- Novel chemical tyrosine functionalization of adeno-associated virus improves gene transfer efficiency in liver and retinaBiomedicine & Pharmacotherapy, 2024
- Intravitreal air tamponade after AAV2 subretinal injection modifies retinal EGFP distributionMolecular Therapy - Methods & Clinical Development, 2023
- Homo‐ and Heterovalent Neoglycoproteins as Ligands for Bacterial LectinsChempluschem, 2021
- Polyvalent Transition‐State Analogues of Sialyl Substrates Strongly Inhibit Bacterial Sialidases**Chemistry – A European Journal, 2020
- Gene Delivery of Alpha-1-Antitrypsin Using Recombinant Adeno-Associated Virus (rAAV)2018
- Asialoglycoprotein receptor mediated hepatocyte targeting — Strategies and applicationsJournal of Controlled Release, 2015
- Lectin Glycoprofiling of Recombinant Therapeutic Interleukin-72013
- Adeno-Associated Virus2011
- Trivalent, Gal/GalNAc-containing ligands designed for the asialoglycoprotein receptorBioorganic & Medicinal Chemistry, 2008